Amanda N. Siriwardana
Sydney, NSW, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Efficacy and safety of canagliflozin are consistent across polypharmacy burden in CKD: the CREDENCE trial.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: September 04, 2026
Non-diabetic kidney disease in patients with diabetes undergoing native kidney biopsy.
Journal: Internal medicine journal
Published: February 05, 2026
Efficacy and Safety of Simultaneous Initiation of SGLT2 Inhibitors and Mineralocorticoid Receptor Antagonists in Patients With Chronic Kidney Disease or Heart Failure: A Systematic Review and Meta-Analysis.
Journal: JACC. Heart failure
Published: December 12, 2025
Sodium-glucose Cotransporter 2 Inhibition in Patients With Type 2 Diabetes and Chronic Kidney Disease Experiencing a Deterioration in Estimated Glomerular Filtration Rate to <20 mL/min/1.73 m2.
Journal: Journal of cardiac failure
Published: December 01, 2025
SGLT2 inhibition in Patients with Type 2 Diabetes and CKD Experiencing a Deterioration in Estimated Glomerular Filtration Rate to <20ml/min/1.73m2.
Journal: Journal of cardiac failure
Published: December 01, 2025
Sex differences in patterns of chronic kidney disease care in Australian primary care: A retrospective cohort study of a national general practice dataset.
Journal: Diabetes, obesity & metabolism
Published: October 28, 2025
Utilizing risk prediction models for older patients with chronic kidney disease.
Journal: Kidney international
Published: February 13, 2025
Glomerular disease registry and biobank: design and baseline results.
Journal: Internal medicine journal
Published: December 15, 2024
Cardiovascular, kidney and safety outcomes with canagliflozin in older adults: A combined analysis from the CANVAS Program and CREDENCE trial.
Journal: Diabetes, obesity & metabolism
Published: October 05, 2024
Estimating a Minimal Important Difference for the EQ-5D-5L Utility Index in Dialysis Patients.
Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Published: June 16, 2023
Last Updated: 09/26/2026